dihexa pnb-0408 c-met hgfr activator HGF/c-MET Signaling in Melanocytes and Melanoma MET – an ideal target
MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Negative control of the HGF c MET pathway by TGF : a new look at the regulation of stemness in glioblastoma Cell Death & Disease Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib Buy Dihexa CAS 1401708 83 5 Rexar Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion PMC
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20




